Futura Medical Soars as Eroxon Launches in US Stores and Online in O...

Futura Medical PLC,(LSE:FUM),has provided additional details regarding the US launch of its innovative erectile dysfunction gel, Eroxon, in collaborat...

Roquefort Therapeutics Secures European Patent for MK Cell Therapy

Roquefort Therapeutics PLC, a company operating within the,Healthcare sector,, has achieved a significant milestone with the European Patent Office gr...

Oncimmune Wins New Contract with Top Ten Global Pharma Company

Oncimmune,(LSE:ONC),, a biotechnology firm, revealed on Monday that it has secured a significant new contract with a leading global pharmaceutical com...

GSK's RSV Vaccine Receives Expanded Approval in Europe

On Thursday, GSK,(LSE:GSK),announced that the European Commission has approved its respiratory syncytial virus (RSV) vaccine, Arexvy, for use in adult...

Totally Secures Multiple New Contracts and Extensions

On Thursday, Totally,(LSE:TLY),, a healthcare services company, announced several new contracts and extensions in England and Ireland, with a total va...

Ananda Developments Publishes Whitepaper on CBD Clinical Research Ga...

Ananda Developments Plc has released a whitepaper detailing the potential therapeutic benefits and scope of cannabidiol (CBD). The document aims to ad...

Totally Shares Surge 10% After £1M New Business Win

Shares of Totally PLC,(LSE:TLY),surged 10% following the announcement of several new contracts and extensions for its urgent and elective care service...

GSK Optimistic on Zantac Lawsuit and Japan Approvals

On Wednesday, GSK,(LSE:GEK),announced several significant updates. The company welcomed a decision from the Delaware Supreme Court to review a lower c...

Polarean Appoints Xenon MRI Expert as Chief Medical Advisor

Polarean Imaging,(LSE:POLX),has announced the appointment of Dr. Chase Hall as its chief medical advisor. Dr. Hall, renowned for his expertise in pulm...

Diaceutics Reports Advancements in Rare-Disease Offerings

Diaceutics,(LSE:DXRX),announced a major enhancement to its rare-disease offerings on Tuesday, marked by the acquisition of a new contract designed to...

Belluscura Shares Surge on Strong Sales and Improved Outlook

Belluscura,(LSE:BELL),, known for its development of lightweight and portable oxygen enrichment technology, reported significant sales growth and an o...

Faron Pharmaceuticals Gains US Fast-Track Approval for Bexmarilimab

Faron Pharmaceuticals Limited,(LSE:FARN),has received fast-track approval from the US Food and Drug Administration (FDA) for its leading drug candidat...

Shield Therapeutics Shares Rise 7% After Canada Approval

Shares in Shield Therapeutics PLC,(LSE:STX),saw a 7% rise in early trading following the approval of its drug, Accrufer (ferric maltol), by Health Can...

AstraZeneca May Shift UK Vaccine Production to the US

AstraZeneca,(LSE:AZN),has indicated that it might relocate its vaccine manufacturing operations from the UK to the United States if ongoing discussion...

GSK (LSE:GSK) Receives US FDA Breakthrough Therapy Designation for B...

GSK plc (LSE/NYSE:GSK) announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to GSK5764227 (GSK'...

AstraZeneca's Imfinzi Receives New US Approval for Early-Stage Lung...

An prominent player of,Healthcare sector,,AstraZeneca PLC has announced that its immunotherapy drug Imfinzi (durvalumab) has been granted an additiona...

IXICO Expects Positive Performance in FY24 with New Contract Wins Bo...

IXICO plc (LSE:IXI), a leading medical imaging and advanced analytics company focused on neuroscience, has issued a promising trading update for the f...

AstraZeneca Becomes First UK-Listed Firm to Hit £200 Billion

AstraZeneca PLC (,LSE:AZN,) has made history as the first company listed on the London Stock Exchange to reach a market valuation exceeding £200 billi...

IQ-AI Moves Closer to FDA Review with Phase 1 Trial Wrap-Up

IQ-AI Ltd has announced that its Phase 1 clinical trial for IB003, a gallium maltolate treatment for children's brain cancer, is nearing completion. T...

Celadon Pharmaceuticals Shares Fall as Funding Delays Impact Financi...

Celadon Pharmaceuticals PLC (LSE: CEL) announced on Monday that it is still awaiting essential cash inflows, though its operations remain aligned with...